Gene therapy: T cells target mutations to fight solid tumors

(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) An international research team from the Max Delbrück Center for Molecular Medicine (MDC) and the Charité (partners in the Berlin Institute of Health, BIH), the Humboldt University Berlin and the University of Chicago has successfully modified immune cells to recognize and specifically target tumor cells in mice. Cancer treatments based on the findings would likely have fewer side effects than standard therapies currentl...